Interestingly, a short isoform of NSD3 lacking catalytic function is also essential in AML progression and directly binds to the Brd4-ET domain, which links Brd4 to the chromatin-remodeling enzyme CHD8 to form a Brd4–NSD3–CHD8 complex. Here, NSD3 is linked to acute myeloid leukemia.